1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
I-SCREEN (Improving Strategies for Cancer Reduction through Early-detection and ENgagement) is sponsored by National Cancer Institute (NCI). This program, involving the University of Colorado Cancer Center, focuses on evaluating the benefits and harms of new cancer screening technologies and their impacts on a representative sample of the U. S.
population.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Funded Early Detection and Screening Grants | Division of Cancer Prevention Funded Early Detection and Screening Grants Active Grants Completed Grants Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma University Of Colorado Denver Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN) Elyse LeeVan, M. D. , M.
P. H. Fred Hutchinson Cancer Center NCI Cancer Screening Research Network: Coordinating and Communication Center Elyse LeeVan, M.
D. , M. P.
H. Fred Hutchinson Cancer Center Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN) Elyse LeeVan, M. D.
, M. P. H.
University Of Oklahoma Hlth Sciences Ctr Oklahoma TRUST Access Hub Elyse LeeVan, M. D. , M.
P. H. Virginia Commonwealth University Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) Elyse LeeVan, M.
D. , M. P.
H. Kaiser Foundation Research Institute Multi-Cancer Early Detection and Screening (MED SCREEN) Study Elyse LeeVan, M. D.
, M. P. H.
Neslund-Dudas, Christine Marie Henry Ford Health + Michigan State University Health Sciences HFH-MSU CSRN ACCrual Enrollment and Screening Site Elyse LeeVan, M. D. , M.
P. H. Univ Of North Carolina Chapel Hill Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB) Elyse LeeVan, M.
D. , M. P.
H. Siteman Cancer Center Catchment CSRN ACCESS Hub Elyse LeeVan, M. D.
, M. P. H.
Weizmann Institute Of Science Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort Fred Hutchinson Cancer Center Statistical Methods for Precision Prevention Massachusetts General Hospital Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls University Of Tx Md Anderson Can Ctr Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data
According to the current listing, eligibility includes: University of Colorado Denver and partner institutions; this is a funded cooperative agreement, not an open solicitation. Confirm the full requirements in the official notice before applying.
Applications for I-SCREEN (Improving Strategies for Cancer Reduction through Early-detection and ENgagement) are due December 31, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
I-SCREEN (Improving Strategies for Cancer Reduction through Early-detection and ENgagement) is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Colorado. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article